MAPK3 and melanoma: In melanoma cells, BRAFV600E causes constitutive activation of the BRAF tyrosine kinase, which phosphorylates and activates the MEK1/2 dual kinase, which in turn phosphorylates and activates its only target, the receptor tyrosine kinase ERK1/2.